Company Overview of InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. develops transformative therapies that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. The company was incorporated in 2009 and is based in San Francisco, California.
150 Post Street
San Francisco, CA 94108
Founded in 2009
Key Executives for InCarda Therapeutics, Inc.
Similar Private Companies By Industry
|Novartis Vaccines and Diagnostics, Inc.||United States|
|Metastatin Pharmaceuticals, Inc.||United States|
|Samaritan Pharmaceuticals, Inc.||United States|
|APP Pharmaceuticals Manufacturing, LLC||United States|
|UPM Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
April 28, 2015
To contact InCarda Therapeutics, Inc., please visit incardatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.